Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

CUSIP: 690469101

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
134,553,130
Total 13F shares
50,111,416
Share change
-1,541,826
Total reported value
$152,838,625
Put/Call ratio
5.1%
Price per share
$3.05
Number of holders
80
Value change
-$4,734,653
Number of buys
38
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q1 2024

As of 31 Mar 2024, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 80 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,111,416 shares. The largest 10 holders included TAKEDA PHARMACEUTICAL CO LTD, EcoR1 Capital, LLC, Rubric Capital Management LP, BlackRock Inc., BVF INC/IL, Madison Avenue Partners, LP, VANGUARD GROUP INC, Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, and JPMORGAN CHASE & CO. This page lists 80 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.